Society for Pediatric Dermatology Poster Presentation: First-in-Human Phase 2 Trial of Zabalafin Hydrogel (AB-101a) – Itch and Quality of Life Pediatric Results - Alphyn

Society for Pediatric Dermatology Poster Presentation: First-in-Human Phase 2 Trial of Zabalafin Hydrogel (AB-101a) – Itch and Quality of Life Pediatric Results

NEWS PROVIDED BY
Alphyn Biologics
July 8, 2024, 19:30 ET

Alphyn SPD Poster Large Format 24 07 08 pr v1

CONTACTS

Corporate:
Neal Koller
nkoller@alphynbiologics.com
(410) 690-8687

Media:
Susan Thomas
susan@endpointcommunications.net
(619) 540-9195